Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2011; 17(11): 1494-1500
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1494
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1494
Table 1 Baseline characteristics-127 patients treated with Histoacryl® -injection therapy
Clinical characteristics of patients | Number | % |
No. of patients (male/female) | 127(97/30) | 76.4/23.6 |
Mean age (yr) | 55.69 | |
Etiology of gastric varices | ||
Liver cirrhosis | 127 | 100 |
Hepatitis B | 50 | 39.3 |
Hepatitis C | 10 | 7.9 |
Alcoholic | 48 | 37.8 |
Unknown | 19 | 15 |
Association of hepatocellular carcinoma | 21 | 16.5 |
Child-pugh classification (A/B/C) | 42/59/26 | 33.1/46.4/20.5 |
Bleeding status | ||
< 24 h | 48 | 37.8 |
> 24 h | 52 | 41 |
Prevention | 27 | 21.2 |
Sarin classification of gastro-esophageal varices | ||
GOV1 | 56 | 44.1 |
GOV2 | 61 | 48 |
IGV1 | 8 | 6.3 |
IGV2 | 2 | 1.6 |
Form of gastric varices | ||
F1 | 15 | 12 |
F2 | 56 | 44.4 |
F3 | 55 | 43.6 |
- Citation: Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, Kim SG, Kim YS, Cheon YK, Cho YD, Kim HS, Kim BS. Long-term result of endoscopic Histoacryl® (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011; 17(11): 1494-1500
- URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1494.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i11.1494